Pasar al contenido principal

DESARROLLO DE ESTRATEGIAS DE INTERVENCION DIRIGIDAS A LA MICROBIOTA INTESTINAL PARA COMBATIR LA DEPRESSION

PID2022-142106OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA EN LA COMUNITAT VALENCIANA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime

  • Medina Rodríguez, Eva M.
  • Martínez Raga, José
  • Sanz Herranz, Yolanda
Depression is a highly prevalent disorder and a leading cause of disability worldwide. It has a major impact on the affected individual and on society as a whole. Regrettably, current available treatments for this condition are insufficient in many patients. In recent years, the gut microbiome has emerged as a promising alternative target for treating and preventing depressive disorders. However, the microbes that form this ecosystem do not act alone but are part of a complicated network connecting the gut and the brain that influences our mood. Host cells that are in intimate contact with gut microbes, such as the epithelial cells forming the gut barrier and the immune cells in their vicinity, play a key role in the process. These cells continuously shape immune responses to maintain healthy communication between gut microbes and the host. In this article, we review how the interplay among epithelial cells, the immune system, and gut microbes mediates gut-brain communication to influence mood. We also discuss how advances in our knowledge of the mechanisms underlying the gut-brain axis could contribute to addressing depression. SIGNIFICANCE STATEMENT: This review does not aim to systematically describe intestinal microbes that might be beneficial or detrimental for depression. We have adopted a novel point of view by focusing on potential mechanisms underlying the crosstalk between gut microbes and their intestinal environment to control mood. These pathways could be targeted by well defined and individually tailored dietary interventions, microbes, or microbial metabolites to ameliorate depression and decrease its important social and economic impact., This work was funded by the Spanish State Research Agency (AEI, Spain) [Grant PID2022-142106OA-I00] and the Miguel Servet program from Carlos III Health Institute (ISCIII, Spain) [Grant CP22/00030], cofunded by the European Union, and supported by the EarlyCause Project of the European Union’s Horizon 2020 Research and Innovation Program [Grant 848158], the European Commission’s NextGenerationEU through the CSIC Interdisciplinary Thematic Platform (PTI+) NEURO-AGING+ (PTI-NEURO-AGING+) and Severo Ochoa grant of the National Agency for Research (AEI)- Spanish Ministry of Science and Innovation (MCIU) (Ref. CEX2021-001189-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Are conventional antidepressants enough? The gut microbiome and nanocarrier-based delivery systems as future prospects for depression treatment

  • Gastaldo Jordán, Isis
  • Villalba Pita, Claudia
  • Martínez-Raga, José
  • Sanz, Yolanda
  • Medina Rodríguez, Eva M.
Depression is the leading cause of disability worldwide and thus a major contributor to the economic burden of disease. In addition to genetic and epigenetic factors, sustained psychological stress linked to modern lifestyles (often characterized by high social expectations, elevated workload and increasing financial needs) may trigger psychiatric diseases such as depression. The effective treatment of this psychiatric condition represents one of the major challenges of our time, due to its skyrocketing increase in prevalence. While conventional antidepressants often provide low response rates and have frequent adverse effects, emerging research is revealing novel and more efficient therapeutic approaches. Notably, the bacteria that populates our intestinal tract, also known as the gut microbiota, is highly susceptible to stress and other factors associated with depression. Therefore, gut microbiota-targeting interventions based on lifestyle modifications or direct supplementation with biotherapeutic agents are being proposed as monotherapy or as adjuvants to conventional treatments. In addition, novel delivery systems, such as nanocarriers, for current antidepressants are being explored to improve drug bioavailability and therapeutic efficiency. This review summarizes the role of the gut microbiota in the pathogenesis of depression and its link with current antidepressant treatments. Furthermore, it explores how strategies like nanoparticle-based delivery systems are paving the way for the next generation of treatments., This work was funded by the Miguel Servet program from Carlos III Health Institute (ISCIII; CP22/00030), and the State Research Agency (AEI; PID2022–142106OA-I00), co-funded by the European Union, the AGROALNEXT program, supported by the Spanish Ministry of Science, Innovation and Universities (MCIU) with funding from European Union NextGenerationEU (PRTR-C17.I1) and Generalitat Valenciana (GVA) (AGROALNEXT/2022/049), and the award to IATA-CSIC as an Accredited Research Center of Excellence “Severo Ocha” (CEX2021–001189-S/MCIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed